InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

- Current share price for ATX : $0.150

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$77 Presentation and Webinar 11 Jun 2024 10:30AM $0.072 $0.150 risen by 108.33%
$77 Amplia Establishes World Class Clinical Advisory Board 3 Jun 2024 8:33AM $0.070 $0.150 risen by 114.29%
$77 Appendix 4G - Key to Corporate Governance Disclosures 30 May 2024 6:53PM $0.067 $0.150 risen by 123.88%
$77 2024 Corporate Governance Statement 30 May 2024 6:45PM $0.067 $0.150 risen by 123.88%
$77 Preliminary Final Report and Annual Report YE 31 March 2024 30 May 2024 6:40PM $0.067 $0.150 risen by 123.88%
$77 ASCO Conference Abstract 24 May 2024 8:37AM $0.063 $0.150 risen by 138.10%
$77 Change of Director's Interest Notice - Dr Robert Peach 21 May 2024 5:11PM $0.058 $0.150 risen by 158.62%
$77 Change of Director's Interest Notice - Jane Bell 21 May 2024 5:10PM $0.058 $0.150 risen by 158.62%
$77 Change of Director's Interest Notice - Chris Burns 21 May 2024 5:09PM $0.058 $0.150 risen by 158.62%
$77 Becoming a substantial holder from SOL 16 May 2024 6:26PM $0.061 $0.150 risen by 147.93%
$77 Notification regarding unquoted securities - ATX 16 May 2024 4:40PM $0.061 $0.150 risen by 147.93%
$77 Change in substantial holding 16 May 2024 3:03PM $0.062 $0.150 risen by 141.94%
$77 Becoming a substantial holder from PCG 16 May 2024 10:56AM $0.061 $0.150 risen by 145.90%
$77 Substantial Holder Notice - Blueflag Holding Pty Ltd 15 May 2024 10:34AM $0.062 $0.150 risen by 141.94%
$77 Application for quotation of securities - ATX 15 May 2024 9:42AM $0.057 $0.150 risen by 163.16%
$77 $4.27m Offer Successfully Completed and ACCENT Trial Update 15 May 2024 9:28AM $0.057 $0.150 risen by 163.16%
$77 Notification of cessation of securities - ATX 13 May 2024 4:25PM $0.057 $0.150 risen by 163.16%
$77 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 8:29AM $0.061 $0.150 risen by 145.90%
$77 Entitlement Offer - Offer Booklet 24 Apr 2024 12:32PM $0.058 $0.150 risen by 158.62%
$77 Proposed issue of securities - ATX 16 Apr 2024 10:08AM $0.085 $0.150 risen by 76.47%
$77 Entitlement Offer Cleansing Statement 16 Apr 2024 10:08AM $0.085 $0.150 risen by 76.47%
$77 Rights Issue Investor Slide Deck 16 Apr 2024 10:08AM $0.085 $0.150 risen by 76.47%
$77 Fully Underwritten 2 for 5 Entitlement Offer to raise $4.27 16 Apr 2024 10:07AM $0.085 $0.150 risen by 76.47%
$77 Trading Halt 12 Apr 2024 9:47AM $0.085 $0.150 risen by 76.47%
$77 AACR Conference Presentation 10 Apr 2024 8:22AM $0.078 $0.150 risen by 92.31%

176 - 200 of 538 results

Page 8 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.